These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 3214597)
1. Low prevalence of infection by HTLV-I in populations at risk for HIV in Djibouti. Fox E; Constantine NT; Abbatte EA; Said-Salah ; Rodier G Ann Inst Pasteur Virol; 1988; 139(4):443-7. PubMed ID: 3214597 [TBL] [Abstract][Full Text] [Related]
2. Monitoring for HIV-1, HIV-2, HTLV-I sero-progression and sero-conversion in a population at risk in east Africa. Constantine NT; Fox E; Rodier G; Abbatte EA J Egypt Public Health Assoc; 1992; 67(5-6):535-47. PubMed ID: 1294680 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic challenges: lymphotropic sero-"questionables". Fox E; Constantine NT; Rodier G; Abbatte EA East Afr Med J; 1992 Oct; 69(10):563-5. PubMed ID: 1473510 [TBL] [Abstract][Full Text] [Related]
4. [HTLV-I infection in sailors who travel to sub-Saharan West Africa]. Pujol E; Ollero M; Márquez P; Gea A; Alcoucer R; Gimeno A Enferm Infecc Microbiol Clin; 1991 May; 9(5):283-5. PubMed ID: 1954264 [TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of HTLV-I/II and HIV-1 infection among male intravenous drug abusers in Chicago. Lentino JR; Pachucki CT; Schaaff DM; Schaefer MR; Holzer TJ; Heynen C; Dawson G; Dorus W J Acquir Immune Defic Syndr (1988); 1991; 4(9):901-9. PubMed ID: 1895212 [TBL] [Abstract][Full Text] [Related]
6. [Evidence of HTLV-1 infection in different groups at risk in Barcelona]. Soriano V; Tor J; Ribera A; Clotet B; Muga R; Pauplana M; Abellá E; Fernández JL; Flores A; Foz M Med Clin (Barc); 1990 Jan; 94(1):5-8. PubMed ID: 2335981 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of HTLV-I/II antibodies in HIV seropositive and HIV seronegative STD patients in Vellore region in southern India. Babu PG; Ishida T; Nesadoss J; John TJ Scand J Infect Dis; 1995; 27(2):105-8. PubMed ID: 7660071 [TBL] [Abstract][Full Text] [Related]
8. Evidence of serological cross-reactivities with human immunodeficiency virus types 1 and 2 and human T-lymphotropic virus types I and II in sera of pregnant women in Ibadan, Nigeria. Olaleye DO; Ekweozor CC; Sheng Z; Rasheed S Int J Epidemiol; 1995 Feb; 24(1):198-203. PubMed ID: 7797344 [TBL] [Abstract][Full Text] [Related]
9. [Antibodies against human T-cell lymphotropic viruses in subjects at high risk for HIV in Monterrey]. Flores-Castañeda MS; Salinas-Carmona MC; Leal-González C; Yáñez-Rodríguez A; Trejo-Avila LM Rev Invest Clin; 1992; 44(1):37-41. PubMed ID: 1523348 [TBL] [Abstract][Full Text] [Related]
10. Human T-lymphotropic virus type I infection in the Solomon Islands. Yanagihara R; Ajdukiewicz AB; Garruto RM; Sharlow ER; Wu XY; Alemaena O; Sale H; Alexander SS; Gajudusek DC Am J Trop Med Hyg; 1991 Feb; 44(2):122-30. PubMed ID: 2012254 [TBL] [Abstract][Full Text] [Related]
11. HTLV-1 in Switzerland: low prevalence of specific antibodies in HIV risk groups, high prevalence of cross-reactive antibodies in normal blood donors. Schüpbach J; Baumgartner A; Tomasik Z Int J Cancer; 1988 Dec; 42(6):857-62. PubMed ID: 3192331 [TBL] [Abstract][Full Text] [Related]
12. Human T cell lymphotropic virus type 1 in Zimbabwe. Houston S; Thornton C; Emmanuel J; Latif A Trans R Soc Trop Med Hyg; 1994; 88(2):170-2. PubMed ID: 8036662 [TBL] [Abstract][Full Text] [Related]
13. Human retroviruses in Amerindians of Colombia: high prevalence of human T cell lymphotropic virus type II infection among the Tunebo Indians. Duenas-Barajas E; Bernal JE; Vaught DR; Nerurkar VR; Sarmiento P; Yanagihara R; Gajdusek DC Am J Trop Med Hyg; 1993 Dec; 49(6):657-63. PubMed ID: 8279632 [TBL] [Abstract][Full Text] [Related]
14. HTLV-I infection in selected populations in Australia and the western Pacific region. Nicholson SR; Efandis T; Dimitrakakis M; Karopoulos A; Lee H; Gust ID Med J Aust; 1992 Jun; 156(12):878-80. PubMed ID: 1463486 [TBL] [Abstract][Full Text] [Related]
16. Human T cell lymphotropic virus type I (HTLV-I) among female prostitutes in Kinshasa, Zaire. Wiktor SZ; Piot P; Mann JM; Nzilambi N; Francis H; Vercauteren G; Blattner WA; Quinn TC J Infect Dis; 1990 Jun; 161(6):1073-7. PubMed ID: 2345292 [TBL] [Abstract][Full Text] [Related]
17. HTLV-I antibody study in normal individuals and unselected hospital patients in Malaysia. Yap SF; Peh SC; Chan L; Wong HC; How VJ; Looi LM Southeast Asian J Trop Med Public Health; 1992 Mar; 23(1):26-9. PubMed ID: 1355930 [TBL] [Abstract][Full Text] [Related]
18. HTLV-I infection in the Free State region of South Africa: a sero-epidemiologic study. van der Ryst E; Joubert G; Smith MS; Terblanche M; Mollentze F; Pretorius AM Cent Afr J Med; 1996 Mar; 42(3):65-8. PubMed ID: 8653770 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of antibodies to human T-lymphotropic virus type 1 (HTLV-1) in an HIV-endemic region of Africa. Maselle SY; Shao JF; Haukenes G East Afr Med J; 1990 Jul; 67(7):461-5. PubMed ID: 2226224 [TBL] [Abstract][Full Text] [Related]
20. HTLV-I/II seropositivity in populations at high risk for HIV-1 infection in Cordoba City, Argentina. Medeot S; Nates S; Gallego S; Sileoni S; Maturano E; Recalde Y; Giordano M; Alvarez RB J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jun; 18(2):187-8. PubMed ID: 9637585 [No Abstract] [Full Text] [Related] [Next] [New Search]